Zydus Wellness Net Sales Up 12.15% in Q2 FY25 Financial Results

On November 11, 2024, Zydus Wellness, a consumer wellness company reported net profit growth of 254.2% for the July-September quarter at ₹209 million. The adjusted PAT growth increased by 154.2% year-on-year after excluding exceptional items. The company achieved a 16.7% year-on-year growth in EBITDA, reaching ₹196 million.

Zydus Wellness Growth Overview from Different Segments

In the food and nutrition category, Glucon-D continued to lead the market with a 59.4% market share, while the glucose powder segment grew by 20.8% on a MAT basis. The Sugar Free brand solidified its dominant position with a commanding 93.9% market share in the sugar substitute category, which saw a 5.4% growth. 

The nutrition drink category is also showing signs of revival, with Complan adding 9,00,000 new households over the past year, according to Kantar Panel’s MAT August 2024 reports. Complan’s market share stood at 4.1%, while the category grew by 2.8%.

In the personal care segment, Nycil and Everyuth delivered strong results. The prickly heat powder segment grew by 21.6% on a MAT basis, with Nycil maintaining its leadership position, holding a 34.3% market share. Nycil’s growth was supported by favourable seasonal conditions and consistent media visibility.

Zydus Wellness Share Price Performance

On November 11, 2024, Zydus Wellness share price opened at 1,934.40 and was trading at 1,917.95 at 2:30 PM on BSE.

About Zydus Wellness

Zydus Wellness, an Indian company is in the making of health and wellness products. A subsidiary of the Zydus Cadila group, it offers a wide range of products in categories such as personal care, healthcare, and nutrition. Some of its popular brands include Sugar Free, Complan, Nutralite, and Everyuth. Zydus Wellness focuses on providing innovative, high-quality solutions to meet the growing consumer demand for health-conscious and wellness-oriented products. The company has a strong presence in both domestic and international markets.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. It is based on several secondary sources on the internet and is subject to changes. Please consult an expert before making related decisions.